County Durham-based technology firm Kromek Group plc has reported a strong first half year performance.
The company has seen major revenue growth across both its advanced imaging and detection divisions.
In unaudited interim results for the six months to October 31, 2025, the AIM-listed business recorded revenues of £15 million, a sharp increase from £3.7 million during the same period last year.
Gross margin rose to 71.7 per cent, and adjusted EBITDA reached a £6 million profit.
Dr Arnab Basu, CEO of Kromek, said: "We are pleased with the strong performance delivered in the first half of the year, with growth achieved across both advanced imaging and CBRN detection.
"Sales in our CBRN segment more than doubled during the period, reflecting the growing global focus on national security and the increasing adoption of our market-leading technologies.
"In advanced imaging, our underlying business saw an increase in revenue driven by renewed engagement with our customers following the completion of our deal with Siemens Healthineers."
The company said its advanced imaging division, supported by its landmark agreement with Siemens Healthineers, played a key role in the results.
The CBRN (chemical, biological, radiological and nuclear) detection segment saw revenues more than double year-on-year due to growing demand from government and international security customers.
Kromek also secured a £6 million revolving credit facility with HSBC to support future growth.
The company is continuing to invest in manufacturing capacity, automation and intellectual property, and now holds more than 190 patents worldwide.
Dr Basu said: "We are seeing good progress as our advanced imaging customers prepare for the launch of their next-generation scanners, reaffirming the value and relevance of our cutting-edge solutions in the market.
"Looking ahead to the second half of the year, with robust customer engagement and a good order book, we expect the momentum achieved in H1 to continue.
"As a result, we remain on track to deliver a full-year performance in line with market expectations, supported by focused execution of our strategy and the continued demand for our innovative technologies."
Kromek, headquartered in Sedgefield, develops radiation and bio-detection technologies for use in medical imaging, security, defence and the civil nuclear sectors.
The company operates manufacturing facilities in both the UK and the US.
Share